https://www.selleckchem.com/B-Raf.html
As the most common biliary ducts, cholangiocarcinoma (CHOL) is an aggressive malignancy with complex pathological context, high mortality and relapse rate. The current therapy of CHOL is mainly performed with surgery followed by chemoradiotherapy. Due to the high metastasis and relapse rate of CHOL, the prognosis of CHOL is still poor, and the molecular prognostic system is to be constructed. In this study, we have established an online prognostic analysis web server named OSchol to evaluate the correlation between candidate genes and survival for
Like
Comment
Share
